Epithelial–mesenchymal transition in cancer development and its clinical significance

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Science

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2009.01419.xPMID 19961486PMCID PMC11159985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Esophageal Squamous Cell Carcinoma

  2012cited by this paper
• Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.

  2009cited by this paper
• Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.

  2009cited by this paper
• miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

  2009cited by this paper
• Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

  2009cited by this paper
• miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

  2009cited by this paper
• Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic.

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Epithelial-to-mesenchymal transition is important to metastasis, but questions remain.

  2008cited by this paper
• MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

  2008cited by this paper
• Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

  2008cited by this paper
• Twist expression in patients with cervical cancer is associated with poor disease outcome.

  2008cited by this paper
• Direct regulation of TWIST by HIF-1α promotes metastasis

  2008cited by this paper
• An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer

  2008cited by this paper
• The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2*

  2008cited by this paper
• Silencing of Transforming Growth Factor-β1 In situ by RNA Interference for Breast Cancer: Implications for Proliferation and Migration In vitro and Metastasis In vivo

  2008cited by this paper
• The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

  2008cited by this paper
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008cited by this paper
• Cancer stem cells and chemoradiation resistance

  2008cited by this paper
• Claudin-1 Protein Expression is a Prognostic Marker of Patient Survival in Renal Cell Carcinomas

  2008cited by this paper
• Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.

  2008cited by this paper
• Role of stem cells in cancer therapy and cancer stem cells: a review

  2007cited by this paper
• Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells.

  2007cited by this paper
• Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors

  2007cited by this paper
• Snail silencing effectively suppresses tumour growth and invasiveness

  2007cited by this paper
• Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

  2007cited by this paper
• Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells

  2007cited by this paper
• Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer

  2007cited by this paper
• Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.

  2007cited by this paper
• Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

  2007cited by this paper
• Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

  2007cited by this paper
• Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?

  2007cited by this paper
• Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

  2007cited by this paper
• Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.

  2007cited by this paper
• Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression

  2007cited by this paper
• Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

  2006cited by this paper
• In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.

  2006cited by this paper
• E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis

  2006cited by this paper
• Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer

  2006cited by this paper
• Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

  2006cited by this paper
• N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors

  2006cited by this paper
• Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

  2006cited by this paper
• Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

  2006cited by this paper
• Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma

  2005cited by this paper
• Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.

  2005cited by this paper
• Breast cancer metastasis: markers and models

  2005cited by this paper
• The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it

  2005cited by this paper
• Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.

  2005cited by this paper
• DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

  2005cited by this paper
• Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways

  2005cited by this paper
• Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer

  2005cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

  2005cited by this paper
• TGF-beta and epithelial-to-mesenchymal transitions.

  2005cited by this paper
• Silencing of microRNAs in vivo with ‘antagomirs’

  2005cited by this paper
• Molecular markers of breast cancer metastasis

  2005cited by this paper
• Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells?

  2005cited by this paper
• Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

  2005cited by this paper
• Migrating cancer stem cells — an integrated concept of malignant tumour progression

  2005cited by this paper
• Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.

  2005cited by this paper
• Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells

  2004cited by this paper
• N-Cadherin Is Regulated by Activin A and Associated with Tumor Aggressiveness in Esophageal Carcinoma

  2004cited by this paper
• Transcriptional regulation of cadherins during development and carcinogenesis.

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Analytical and Clinical Evaluation of a New Urinary Tumor Marker: Bladder Tumor Fibronectin in Diagnosis and Follow-up of Bladder Cancer

  2003cited by this paper
• Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

  2003cited by this paper
• Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

  2003cited by this paper
• E-cadherin expression in primary carcinomas of the breast and its distant metastases

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Association between fibronectin expression and prognosis in ovarian carcinoma.

  2003cited by this paper
• Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.

  2003cited by this paper
• Metastasis: Dissemination and growth of cancer cells in metastatic sites

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• The SLUG zinc-finger protein represses E-cadherin in breast cancer.

  2002cited by this paper
• Circulating breast cancer cells are frequently apoptotic.

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

  2001cited by this paper
• Possible contribution of CD44 variant 6 and nuclear β‐catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma

  2001cited by this paper
• The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.

  2001cited by this paper
• Role of transforming growth factor beta in human disease.

  2000cited by this paper
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000cited by this paper
• Induction and regulation of epithelial-mesenchymal transitions.

  2000cited by this paper
• Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis

  1999cited by this paper
• Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients.

  1999cited by this paper
• General mechanisms of metastasis

  1997cited by this paper
• Vimentin‐positive adenocarcinomas of the stomach: co‐expression of vimentin and cytokeratin

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper

• SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in Mesothelioma

  2026cites this paper
• Insights Into the Crosstalk of HIF and Autophagy: Regulation Mechanisms and Therapeutic Potentials in Cancer

  2026cites this paper
• Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls.

  2025cites this paper
• Y-chromosome alteration and its impact on cancer progression and metastasis

  2025cites this paper
• Exploration Biomarkers for Recurrence of Hepatocellular Carcinoma After Liver Transplantation Based on Bioinformatics Analysis.

  2025cites this paper
• Clinical implications of epithelial-to-mesenchymal transition in cancers which potentially spread to peritoneum

  2025cites this paper
• Oxamate, an LDHA Inhibitor, Inhibits Stemness, Including EMT and High DNA Repair Ability, Induces Senescence, and Exhibits Radiosensitizing Effects in Glioblastoma Cells

  2025cites this paper
• Observation of Field Cancerization in Human Breast Tissue with Raman Hyperspectral Imaging and Artificial Neural Networks

  2025cites this paper
• Research Progress on MAZ in Malignant Tumors

  2025cites this paper
• EpCAM activates the ERK-EGR1 signaling axis and promotes TNF-α-induced the progression of anaplastic thyroid cancer

  2025cites this paper
• Molecular typing of gliomas on the basis of integrin family genes and a functional study of ITGA7

  2025cites this paper
• β-Catenin Drives the FOXC2-Mediated Epithelial–Mesenchymal Transition and Acquisition of Stem Cell Properties

  2025cites this paper
• AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

  2024cites this paper
• Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential.

  2024cites this paper
• Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.

  2024cites this paper
• Dual roles of myeloid-derived suppressor cells in various diseases: a review

  2024cites this paper
• Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.

  2024cites this paper
• Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-κB pathway.

  2024cites this paper
• Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer

  2024cites this paper
• In Silico Evaluation of Some Computer-Designed Fluoroquinolone–Glutamic Acid Hybrids as Potential Topoisomerase II Inhibitors with Anti-Cancer Effect

  2024cites this paper
• Leaf Extract from European Olive (Olea europaea L.) Post-Transcriptionally Suppresses the Epithelial-Mesenchymal Transition and Sensitizes Gastric Cancer Cells to Chemotherapy

  2024cites this paper
• Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders

  2024cites this paper
• Oxygen Nanobubbles Halt Tumor Aggression and Metastasis by Inhibiting Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Lung and Mammary Adenocarcinoma

  2024cites this paper
• Prognostic significance of non-coding RNAs related to the tumorigenic epithelial-mesenchymal transition (EMT) process among ovarian cancer patients: A systematic review and meta-analysis

  2024cites this paper
• Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta‐analysis of 31 prospective cohorts and Mendelian randomization study

  2024cites this paper
• Association of M2 macrophages with EMT in glioma identified through combination of multi-omics and machine learning

  2024cites this paper
• Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.

  2024cites this paper
• Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition.

  2024cites this paper
• Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer

  2024cites this paper
• Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma

  2024cites this paper
• Association between the expression of epithelial–mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer

  2024cites this paper
• Exploring the influence of microgravity on chemotherapeutic drug response in cancer: Unveiling new perspectives

  2024cites this paper
• FTH1-Expressing Circulating Tumor Cells as Predictors of Neoadjuvant Chemotherapy Response in Non-Metastatic Breast Cancer: A Prospective Cohort Study

  2024cites this paper
• Emerging trends in gastrointestinal cancers: Targeting developmental pathways in carcinogenesis and tumor progression.

  2024cites this paper
• TFAP2A downregulation mediates tumor-suppressive effect of miR-8072 in triple-negative breast cancer via inhibiting SNAI1 transcription

  2024cites this paper
• Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer.

  2024cites this paper
• Decreased Expression of PLD2 Promotes EMT in Colorectal Cancer Invasion and Metastasis

  2024cites this paper
• DEC1 is involved in TGF-β1-induced epithelial-mesenchymal transition of gastric cancer.

  2024cites this paper
• Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation

  2024cites this paper
• YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells

  2024influential citation
• The Role of PRMT5 in Immuno-Oncology

  2023cites this paper
• Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application

  2023cites this paper
• The Association between Metabolic Syndrome and Epithelial Cell Abnormalities Detected on Pap Smear: A Nationwide Population-Based Study

  2023cites this paper
• The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis: Recent Advances.

  2023cites this paper
• DNA bridged polycrystalline Cu2+-NMOFs for electrochemical detection of mesenchymal circulating tumor cells

  2023cites this paper
• Association of FTH1-Expressing Circulating Tumor Cells With Efficacy of Neoadjuvant Chemotherapy for Patients With Breast Cancer: A Prospective Cohort Study

  2023cites this paper
• De novo and histologically transformed small cell lung cancer is sensitive to lurbinectedin treatment through the modulation of EMT and NOTCH signaling pathways.

  2023cites this paper
• Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models

  2023cites this paper
• P2 X 7 receptor is a critical regulator of extracellular ATP-induced profibrotic genes expression in rat kidney: implication of transforming growth factor-β/Smad signaling pathway

  2023cites this paper
• TRP Channels in Cancer: Signaling Mechanisms and Translational Approaches

  2023cites this paper
• Long-chain perfluoroalkyl carboxylates induce cytoskeletal abnormalities and activate epithelial-mesenchymal transition in both renal cell carcinoma 3D cultures and Caki-1 xenografted mouse model.

  2023cites this paper
• Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker

  2023cites this paper
• Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis

  2023cites this paper
• Interaction between miR‑206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma

  2023cites this paper
• Label free identification of different cancer cells using deep learning-based image analysis

  2023cites this paper
• The roles of FHL2 in cancer

  2023cites this paper
• MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil.

  2023cites this paper
• Structural analysis of factors related to FAM3C/ILEI dimerization and identification of inhibitor candidates targeting cancer treatment

  2023cites this paper
• Nanotechnology-empowered lung cancer therapy: From EMT role in cancer metastasis to application of nanoengineered structures for modulating growth and metastasis.

  2023cites this paper
• AMPK-like proteins and their function in female reproduction and gynecologic cancer.

  2023cites this paper
• High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist

  2023cites this paper
• Evaluation of tumor budding and its correlation with histomorphological prognostic markers in oral squamous cell carcinoma and its association with the epithelial-mesenchymal transition process

  2023cites this paper
• RETRACTED ARTICLE: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer

  2023cites this paper
• Comprehensive Glycoprofiling of Oral Tumors Associates N-Glycosylation With Lymph Node Metastasis and Patient Survival

  2023cites this paper
• Simultaneous Proximity DNAzyme-Activated Duplexed Protein-Specific Glycosylation Imaging on Cell Surface via Bioorthogonal Chemistry.

  2023cites this paper
• Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma

  2023cites this paper
• miR-145-5p suppresses cell proliferation by targeting IGF1R and NRAS genes in multiple myeloma cells

  2023cites this paper
• Role of Twist and Vascular Endothelial Growth Factor in behavior of odontogenic cysts

  2022cites this paper
• Synthesis and in silico anti-metastatic evaluation of carvacrol derivative, 2-hydroxy-6-isopropyl-3-methylbenzalehyde

  2022cites this paper
• Microfluidic Lab-on-a-Chip for Studies of Cell Migration under Spatial Confinement

  2022cites this paper
• Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes

  2022cites this paper
• Resveratrol as a Chemopreventive Agent in Lung Cancer Therapy

  2022cites this paper
• Thwarting of Lphn3 Functions in Cell Motility and Signaling by Cancer-Related GAIN Domain Somatic Mutations

  2022cites this paper
• The role of inflammations and EMT in carcinogenesis

  2022cites this paper
• CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect in Tumor and Non-Tumor Diseases

  2022cites this paper
• Sirtuins and Hypoxia in EMT Control

  2022cites this paper
• Epithelial to Mesenchymal Transition in Lung Cancer: Potential EMT-Targeting Natural Product-derived Compounds

  2022cites this paper
• Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

  2022cites this paper
• Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines.

  2022cites this paper
• Overexpression of Adenovirus E1A Reverses Transforming Growth Factor-β-induced Epithelial-mesenchymal Transition in Human Esophageal Cancer Cells.

  2022cites this paper
• miR-200b, ZEB2 and PTPN13 Are Downregulated in Colorectal Carcinoma with Serosal Invasion

  2022cites this paper
• HuR confers IL-17a-induced migration and invasion of gastric cancer cells via upregulation of Snail translation.

  2022cites this paper
• Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease

  2022cites this paper
• MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells

  2022cites this paper
• Betulonic Acid, as One of the Active Components of the Celastrus orbiculatus Extract, Inhibits the Invasion and Metastasis of Gastric Cancer Cells by Mediating Cytoskeleton Rearrangement In Vitro

  2022cites this paper
• MiR-590 suppresses the progression of non-small cell lung cancer by regulating YAP1 and Wnt/β-catenin signaling

  2022cites this paper
• Deletion of arylamine N‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis

  2022cites this paper
• Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer

  2022cites this paper
• Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance.

  2022cites this paper
• EMT in salivary gland tumors: the expression of microRNAs miR-155 and miR-200c is associated with clinical-pathological parameters

  2022cites this paper
• EMT and Tumor Turning Point Analysis in 3D Spheroid Culture of HNSCC and Mesenchymal Stem Cells

  2022cites this paper
• Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition

  2022cites this paper
• Dietary Diindolylmethane Enhances the Therapeutic Effect of Centchroman in Breast Cancer by Inhibiting Neoangiogenesis

  2022cites this paper
• Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma

  2022cites this paper
• Identification of key somatic oncogenic mutation based on a confounder-free causal inference model

  2022cites this paper
• Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma

  2021cites this paper
• Nrf2 regulates cell motility through RhoA–ROCK1 signalling in non-small-cell lung cancer cells

  2021cites this paper
• Tiny miRNAs Play a Big Role in the Treatment of Breast Cancer Metastasis

  2021cites this paper
• Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy

  2021cites this paper
• Warthy-Basaloid Squamous Cell Carcinoma of Penile – Case Report

  2021cites this paper